This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bickell, N. A. Articles by Guth, A. A. Search for Related Content PubMed PubMed Citation Articles by Bickell, N. A. Articles by Guth, A. A.

Missed Opportunities: Racial Disparities in Adjuvant Breast Cancer Treatment

Nina A. Bickell, Jason J. Wang, Soji Oluwole, Deborah Schrag, Henry Godfrey, Karen Hiotis, Jane Mendez, Amber A. Guth

From the Department of Health Policy, Mount Sinai School of Medicine; Department of Surgery, Harlem Hospital Center, Columbia University College of Physicians and Surgeons; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center; Department of Surgery, North General Hospital; Department of Surgery, Bellevue Hospital and New York University School of Medicine; Department of Surgery, Metropolitan Hospital Center; Department of Surgery, New York University School of Medicine, New York, NY

Address reprint requests to Nina A. Bickell, MD, MPH, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, Box 1077, New York, NY 10029; e-mail: nina.bickell{at}mssm.edu

PURPOSE: Underuse of adjuvant therapy is a potentially important and remediable explanation for the inferior survival of minority women with breast cancer. We sought to measure a racial disparity in the underuse of adjuvant treatments for early-stage breast cancer and to identify associated factors.

METHODS: Cross-sectional study with review of all inpatient and outpatient medical records of 677 women treated surgically for a primary American Joint Committee on Cancer stage I or II breast cancer in 1999 to 2000. Underuse was defined as omissions of radiation therapy after breast-conserving surgery, adjuvant chemotherapy after resection of hormone-receptor-negative tumors 1 cm, or hormonal therapy for receptor-positive tumors 1 cm.

RESULTS: One hundred forty-five (21%) of 677 women experienced underuse of appropriate adjuvant therapy: 16% in whites, 34% in blacks, and 23% in Hispanics (P < .001). Women referred to medical oncologists were less likely to experience underuse of necessary adjuvant treatments (relative risk [RR] for underuse = 0.2; 95% CI, 0.1 to 0.3). Women who were minorities (RR = 2.0; 95% CI, 1.3 to 3.1), had higher levels of comorbidity (RR = 1.4; 95% CI, 1.1 to 1.8) and lacked insurance (RR = 1.9; 95% CI, 0.9 to 4.0) were at greater risk for underuse.

CONCLUSION: Minority women with early-stage breast cancer have double the risk of white women for failing to receive necessary adjuvant treatments despite rates of oncologic consultation similar to those for white women. Oncology referrals are necessary to reduce treatment disparities but are not sufficient to ensure patients' receipt of efficacious adjuvant treatment.

Supported by the AHRQ (Grant No. P-01HS10859-02), Commonwealth Fund (Grant No. 20010102), and NCMHHD (Grant No. P60 MD00270).

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

This article has been cited by other articles:

				D. L. Hershman, R. B. McBride, A. Eisenberger, W. Y. Tsai, V. R. Grann, and J. S. Jacobson Doxorubicin, Cardiac Risk Factors, and Cardiac Toxicity in Elderly Patients With Diffuse B-Cell Non-Hodgkin's Lymphoma J. Clin. Oncol., July 1, 2008; 26(19): 3159 - 3165. [Abstract] [Full Text] [PDF]

				N. F. Esnaola, K. Knott, C. Finney, M. Gebregziabher, and M. E. Ford Urban/Rural Residence Moderates Effect of Race on Receipt of Surgery in Patients with Nonmetastatic Breast Cancer: A Report from the South Carolina Central Cancer Registry Ann. Surg. Oncol., July 1, 2008; 15(7): 1828 - 1836. [Abstract] [Full Text] [PDF]

				B. N. Polite, C. Cirrincione, G. F. Fleming, D. A. Berry, A. Seidman, H. Muss, L. Norton, C. Shapiro, K. Bakri, K. Marcom, et al. Racial Differences in Clinical Outcomes From Metastatic Breast Cancer: A Pooled Analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B J. Clin. Oncol., June 1, 2008; 26(16): 2659 - 2665. [Abstract] [Full Text] [PDF]

				D. B. Smith, Z. Feng, M. L. Fennell, J. S. Zinn, and V. Mor Separate And Unequal: Racial Segregation And Disparities In Quality Across U.S. Nursing Homes Health Aff., September 1, 2007; 26(5): 1448 - 1458. [Abstract] [Full Text] [PDF]

				N. A. Bickell, F. LePar, J. J. Wang, and H. Leventhal Lost Opportunities: Physicians' Reasons and Disparities in Breast Cancer Treatment J. Clin. Oncol., June 20, 2007; 25(18): 2516 - 2521. [Abstract] [Full Text] [PDF]

				J. J. Griggs, E. Culakova, M. E.S. Sorbero, M. S. Poniewierski, D. A. Wolff, J. Crawford, D. C. Dale, and G. H. Lyman Social and Racial Differences in Selection of Breast Cancer Adjuvant Chemotherapy Regimens J. Clin. Oncol., June 20, 2007; 25(18): 2522 - 2527. [Abstract] [Full Text] [PDF]

				N. J. Meropol and K. A. Schulman Cost of Cancer Care: Issues and Implications J. Clin. Oncol., January 10, 2007; 25(2): 180 - 186. [Abstract] [Full Text] [PDF]